BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $206,000 | -2.4% | 2,445 | 0.0% | 0.06% | -27.2% |
| Q2 2020 | $211,000 | +3.4% | 2,445 | 0.0% | 0.08% | +6.6% |
| Q4 2019 | $204,000 | -4.7% | 2,445 | 0.0% | 0.08% | -13.6% |
| Q3 2019 | $214,000 | -14.7% | 2,445 | -20.2% | 0.09% | -15.4% |
| Q2 2019 | $251,000 | +0.8% | 3,065 | 0.0% | 0.10% | -2.8% |
| Q1 2019 | $249,000 | +23.3% | 3,065 | 0.0% | 0.11% | +10.3% |
| Q4 2018 | $202,000 | -24.1% | 3,065 | -11.0% | 0.10% | -16.4% |
| Q3 2018 | $266,000 | +4.7% | 3,445 | 0.0% | 0.12% | -4.9% |
| Q2 2018 | $254,000 | +13.4% | 3,445 | 0.0% | 0.12% | +7.0% |
| Q1 2018 | $224,000 | -5.5% | 3,445 | -6.0% | 0.11% | -1.7% |
| Q4 2017 | $237,000 | -15.7% | 3,665 | -18.2% | 0.12% | -20.5% |
| Q3 2017 | $281,000 | +3.7% | 4,480 | 0.0% | 0.15% | -2.7% |
| Q2 2017 | $271,000 | +16.8% | 4,480 | 0.0% | 0.15% | +13.6% |
| Q1 2017 | $232,000 | +8.9% | 4,480 | 0.0% | 0.13% | +1.5% |
| Q3 2016 | $213,000 | +4.9% | 4,480 | 0.0% | 0.13% | +5.7% |
| Q2 2016 | $203,000 | -30.5% | 4,480 | -41.4% | 0.12% | -35.3% |
| Q4 2015 | $292,000 | -34.5% | 7,640 | -43.7% | 0.19% | -38.1% |
| Q3 2015 | $446,000 | -76.8% | 13,575 | -50.6% | 0.31% | -75.3% |
| Q2 2015 | $1,924,000 | +5.4% | 27,505 | +3.2% | 1.24% | +5.3% |
| Q1 2015 | $1,826,000 | -0.8% | 26,660 | +6.2% | 1.18% | -2.3% |
| Q4 2014 | $1,840,000 | +9.2% | 25,110 | +7.0% | 1.21% | +4.0% |
| Q3 2014 | $1,685,000 | +0.2% | 23,470 | +0.9% | 1.16% | +0.2% |
| Q2 2014 | $1,682,000 | -1.8% | 23,270 | 0.0% | 1.16% | -4.6% |
| Q1 2014 | $1,712,000 | – | 23,270 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |